Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Nov 9, 2023
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Purchase
Class A Common Stock
2023-11-07$1.98/sh+2,500$4,950→ 446,955 total - Purchase
Class A Common Stock
2023-11-07$2.01/sh+2,500$5,025→ 449,455 total
Footnotes (1)
- [F1]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.